As you age, it’s not just about lines and wrinkles. Your cheeks can lose volume and skin may begin to sag. Juvederm Voluma XC® is the first FDA approved injectable gel to instantly add volume to your cheek area to correct age related volume loss in adults over the age of 21. It can provide you contour and a subtle lift for up to two years with optimal treatment.
Juvederm Voluma XC®
is a hyaluronic acid soft tissue filler. It is formulated with lidocaine for added comfort during treatment.
What makes Juvederm Voluma XC® different?
The loss of midface volume is one of the hallmarks of facial aging. This occurs in varying degrees of severity and can lead to significant changes in facial appearance. One of the most noticeable changes is the loss of cheekbone definition. In the past, this was addressed with surgery to tighten the overlying skin and lift the deeper soft tissues. More recently, volumizing fillers have been used to provide a similar lift without surgery. The goal is to restore volume in the midface to create a natural, youthful face.
Juvederm Voluma XC® is cross-linked through a process called Vycross which helps provide excellent lifting capacity. This special cross-linking also helps to avoid degradation, and studies have shown that Juvederm Voluma XC® can list up to two years. Also, since it is a HA filler, it can be molded and shaped into the desired contour after injection.
Who is a candidate for Juvederm Voluma XC®?
Anyone with volume loss in their midface is a candidate or treatment with Juvederm Voluma XC®, as well as individuals with poorly defined cheekbones. Patients in their 30’s, 40’s, and 50’s may not be appropriate candidates for surgery but may benefit instead from a Juvederm Voluma XC® treatment. Patients in their 60’s and beyond who have more significant skin laxity and volume loss tend to require more filler volume. While these patients are often good candidates for surgery, they often choose volumizing filler treatments due to surgery concerns such as anesthesia and potential complications.